|
Abstract: Objective To investigate the value of serum microRNA-25-3p (miR-25-3p) and
microRNA-425-5p (miR-425-5p) on the diagnosis of chronic inflammation of liver in chronic
hepatitis B (CHB) patients with persistently normal alanine aminotransferase (ALT). Methods
A total of 118 patients with CHB admitted to The Fourth People’s Hospital of Qinghai Province
from March 1st, 2021 to March 31st, 2024 were selected as the research objects. According
to the grading of liver inflammation activity (G) based on liver biopsy, there were 49 cases
in G0/G1 group, 49 cases in G2 group and 20 cases in G3/G4 group. The levels of ALT,
aspartate aminotransferase (AST), total bilirubin (TBil) and albumin (ALB) of the patients
were collected. The serum levels of miR-25-3p and miR-425-5p were detected by quantitative
reverse transcription polymerase chain reaction (qRT-PCR). Spearman correlation analysis was
used to analyze the correlations between the levels of miR-25-3p, miR-425-5p and the liver
inflammation activity. Pearson correlation analysis was used to analyze the correlations between
the levels of miR-25-3p, miR-425-5p and levels of AST, TBil and ALB. Receiver operating
characteristic (ROC) curves was used to evaluate the value of serum miR-25-3p and miR-425-5p
levels on predicting liver inflammation activity grade G ≥ 2 in patients with chronic hepatitis
B (CHB). Results Compared with patients in G0/G1 group, patients in G2 group and G3/G4 group
showed significantly higher levels of AST [(35.19 ± 7.48) U/L vs. (51.27 ± 10.91) U/L vs. (28.19 ±
7.19) U/L], TBil [(16.43 ± 3.42) µmol/L vs. (23.73 ± 5.26) µmol/L vs. (10.18 ± 2.18) µmol/L] and
relative expression of miR-25-3p (2.43 ± 0.67 vs. 3.49 ± 0.74 vs. 1.02 ± 0.31). In contrast, the
levels of ALB [(39.78 ± 8.35) g/L vs. (35.06 ± 7.48) g/L vs. (45.68 ± 9.98) g/L] and relative
expression of miR-425-5p (0.64 ± 0.22 vs. 0.42 ± 0.13 vs. 1.04 ± 0.32) were significantly
lower (all P < 0.05). Compared with patients in G2 group, patients in G3/G4 group exhibited
significantly higher levels of AST, TBil and relative expression of miR-25-3p, while ALB
levels and relative expression of miR-425-5p were significantly lower (all P < 0.05).
Spearman correlation analysis showed that serum miR-25-3p level was positively correlated
with liver inflammation activity (rs = 0.576, P = 0.026) and miR-425-5p level was negatively
correlated with liver inflammation activity (rs = -0.458, P = 0.017). Pearson analysis showed
that miR-25-3p level was positively correlated with AST and TBil (r = 0.516, P < 0.001;
r = 0.476, P = 0.008), and negatively correlated with ALB (r = -0.473, P = 0.009); miR-425-5p level
was negatively correlated with AST and TBil (r = -0.506, P < 0.001; r = -0.462, P =
0.011), and positively correlated with ALB (r = 0.481, P = 0.004). The area under ROC curve
of miR-25-3p + miR-425-5p (0.923) for predicting liver inflammation activity grade G ≥ 2
in CHB patients was significantly larger than that predicted by miR-25-3p alone (0.859) or
miR-425-5p alone (0.836) (Z = 2.305, P = 0.021; Z = 2.786, P = 0.005). Conclusions Some
CHB patients with persistently normal ALT levels have severe chronic liver inflammation.
Serum levels of miR-25-3p and miR-425-5p have certain value on evaluating chronic liver
inflammation in CHB patients.
|